Skip to main content

MYDA Advisors LLC

Position in TERN — Terns Pharmaceuticals, Inc.

CIK 1589689 WOODMERE, NY

Position in TERN

as of Mar 31, 2026 · filed May 14, 2026
Position Value
$2,108,800
+$1,379,050 QoQ
Shares Held
40,000
-54.3% QoQ
Ownership
0.035%
of shares outstanding
% of Portfolio
0.61%
of 13F equity value
Holder Rank
#170
of 316 holders
Holding Since
Dec 2023
5 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in TERN Over Time

Shares Held

Position Value (USD)

Derivatives in TERN

reported options exposure · as of Sep 30, 2024
CallValue
$83,400
CallShares
10,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

MYDA Advisors LLC holds $37,336,697 across 11 Biotechnology names. TERN ranks #6 (5.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
6 TERN
Terns Pharmaceuticals, Inc.
This page
40,000 $2,108,800

All Filings in TERN

Export CSV
9 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $2,108,800 40,000
2024-09-30 $83,400 10,000
2024-09-30 $729,750 87,500
2024-06-30 $272,400 40,000
2024-06-30 $953,400 140,000
2024-03-31 $197,456 30,100
2024-03-31 $918,400 140,000
2023-12-31 $129,800 20,000
2023-12-31 $924,065 142,383